Maternal and Perinatal Outcomes in Pregnant Women With Comorbid Inflammatory Bowel Disease and Chronic Liver Disease
Coexisting IBD and CLD confer compounded maternal and perinatal risks beyond either condition alone. Multidisciplinary care and risk-based screening for underlying CLD in pregnant women are warranted.
Authors
- Melissa Spiel (ORCID: https://orcid.org/0000-0002-6914-7006)
- Lauren Tal Grinspan (ORCID: https://orcid.org/0000-0001-7455-280X)
- Jessica D. Lee (ORCID: https://orcid.org/0000-0002-8409-3632)
- Loren Rabinowitz (ORCID: https://orcid.org/0000-0002-6673-4096)
- Adam S. Cheifetz (ORCID: https://orcid.org/0000-0002-6010-1896)
- Tatyana Kushner (ORCID: https://orcid.org/0000-0001-6663-6253)
- Konstantinos Papamichael (ORCID: https://orcid.org/0000-0003-1497-0254)
Institutions
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- Cornell University (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1111/apt.70425
- Citations
- 2
- Primary Topic
- Pregnancy and Medication Impact
- Type
- article
- Field-Weighted Citation Impact
- 3.76